Zhang Xiangtong, Wang Peiqin, Wan Zhi, Xiong Ping, Rao Dandan, Yu Zhangbin, Wu Genfeng
Department of Pediatrics, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, Guangdong, China.
Department of Neonatology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
Front Pediatr. 2025 Aug 18;13:1628472. doi: 10.3389/fped.2025.1628472. eCollection 2025.
Survival without major morbidity (SWMM) in very preterm infants represents a critical outcome measure in neonatal care. This systematic review evaluates both the prevalence of SWMM among infants born before 32 weeks' gestation and the associated risk factors.
We conducted a comprehensive search of PubMed, Web of Science, Embase, Cochrane Library, Scopus, CNKI, CBM, and Wanfang databases from inception through February 4, 2025. Two independent reviewers performed study selection and data extraction. Study quality was assessed using the Agency for Healthcare Research and Quality (AHRQ) checklist for cross-sectional studies and the Newcastle-Ottawa Scale (NOS) for cohort studies. Pooled prevalence was calculated using a random-effects model. Heterogeneity was explored through subgroup analyses and meta-regression, and publication bias was assessed via funnel plots and further evaluated with trim-and-fill analysis. Risk factors were evaluated using multivariate meta-analysis of adjusted odds ratios (ORs) with 95% confidence intervals (CIs).
From 1,606 screened articles, 35 studies spanning twelve countries met inclusion criteria. The pooled SWMM incidence was 47% (95% CI: 40%-54%), with notable gestational age stratification: 67% (95% CI: 62%-72%) for infants <32 weeks vs. 44% (95% CI: 26%-61%) for those <28 weeks. Meta-analysis identified gestational age maturity (OR: 1.65; 95% CI: 1.50-1.81), antenatal corticosteroid administration (OR: 1.46; 95% CI: 1.12-1.89), and higher 5-minute Apgar scores (OR: 1.21; 95% CI: 1.06-1.37) as positive predictors of SWMM. Conversely, male sex (OR: 0.62; 95% CI: 0.55-0.71) and hemodynamically significant patent ductus arteriosus (OR: 0.51; 95% CI: 0.38-0.69) showed negative associations with SWMM.
The review reports a 47% SWMM rate among very preterm infants, with higher rates observed in infants of later gestational age. Key predictors include gestational age, 5-minute Apgar score, and antenatal corticosteroids, while male sex and patent ductus arteriosus are associated with reduced SWMM. Limitations include heterogeneity in SWMM definitions and geographic variability. Future research should focus on standardizing outcome measures and validating risk factors through multinational studies.
https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641924, PROSPERO CRD42025641924.
极早产儿无严重并发症存活(SWMM)是新生儿护理中的一项关键结局指标。本系统评价评估了妊娠32周前出生婴儿中SWMM的发生率及其相关危险因素。
我们对PubMed、Web of Science、Embase、Cochrane图书馆、Scopus、中国知网、中国生物医学文献数据库和万方数据库进行了全面检索,检索时间从建库至2025年2月4日。两名独立评审员进行研究筛选和数据提取。使用医疗保健研究与质量局(AHRQ)横断面研究清单和纽卡斯尔-渥太华量表(NOS)对队列研究进行研究质量评估。采用随机效应模型计算合并患病率。通过亚组分析和meta回归探讨异质性,并通过漏斗图评估发表偏倚,并用剪补法进一步评估。使用调整比值比(OR)及其95%置信区间(CI)的多变量meta分析评估危险因素。
在1606篇筛选文章中,来自12个国家的35项研究符合纳入标准。SWMM合并发生率为47%(95%CI:40%-54%),孕周分层明显:孕周<32周的婴儿为67%(95%CI:62%-72%),而孕周<28周的婴儿为44%(95%CI:26%-61%)。meta分析确定孕周成熟度(OR:1.65;95%CI:1.50-1.81)、产前使用糖皮质激素(OR:1.46;95%CI:1.12-1.89)和5分钟Apgar评分较高(OR:1.21;95%CI:1.06-1.37)是SWMM的阳性预测因素。相反,男性(OR:0.62;95%CI:0.55-0.71)和血流动力学显著的动脉导管未闭(OR:0.51;95%CI:0.38-0.69)与SWMM呈负相关。
该评价报告极早产儿的SWMM发生率为47%,孕周较大的婴儿发生率较高。关键预测因素包括孕周、5分钟Apgar评分和产前糖皮质激素,而男性和动脉导管未闭与SWMM降低有关。局限性包括SWMM定义的异质性和地理变异性。未来的研究应侧重于标准化结局指标,并通过多国研究验证危险因素。
https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641924,PROSPERO CRD42025641924 。